abstract |
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, methods for their preparation, compositions containing them, and diseases related to or characterized by LRRK2 kinase activity, such as Parkinson's disease. There is provided their use in the treatment or prevention of Alzheimer's disease and amyotrophic lateral sclerosis (ALS). |